Skip to content

Drug interactions

Indacaterol-glycopyrronium + Triptorelin

Severity: Moderate

Indacaterol-glycopyrronium and Triptorelin: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Androgen deprivation therapy such as triptorelin can prolong the QT interval, and indacaterol may add to repolarization risk, especially with hypokalemia. The clinical risk is modest but relevant in patients with cardiac disease.

What this interaction means in plain words

Indacaterol-glycopyrronium and Triptorelin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Indacaterol-glycopyrronium belongs to Respiratory; Triptorelin belongs to Endocrine.

Evidence level: Low

Why it happens

Additive QT prolongation.

What to do

Review cardiac risk factors and obtain an ECG where indicated. Keep potassium and magnesium within normal range.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Indacaterol-glycopyrronium and Triptorelin, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Indacaterol-glycopyrronium with Triptorelin?

MediHelp rates the interaction as moderate. Indacaterol-glycopyrronium and Triptorelin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Androgen deprivation therapy such as triptorelin can prolong the QT interval, and indacaterol may add to repolarization risk, especially with hypokalemia. The clinical risk is modest but relevant in patients with cardiac disease.

How serious is the interaction between Indacaterol-glycopyrronium and Triptorelin?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Review cardiac risk factors and obtain an ECG where indicated. Keep potassium and magnesium within normal range.

What other medicines interact with Indacaterol-glycopyrronium?

MediHelp also lists interactions of Indacaterol-glycopyrronium with, for example, Amisulpride, Arformoterol, Arsenic trioxide. The full list is on the Indacaterol-glycopyrronium page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in